ERT Asia Group

Clario, formerly known as ERT (eResearchTechnology), is a leading global provider of clinical trial technology and endpoint data solutions. The company specializes in electronic Clinical Outcome Assessments (eCOA), cardiac safety monitoring, respiratory diagnostics, and medical imaging services. ERT Asia Group represents the company's strategic operations within the Asia-Pacific region, providing localized support for global pharmaceutical and biotechnology clients. In 2021, ERT merged with Bioclinica to form Clario, creating a comprehensive platform for high-quality clinical evidence generation. The company's technology is used to improve the accuracy and reliability of data in clinical trials across all therapeutic areas and phases.